Indirect costs associated with ulcerative colitis: a systematic literature review of real-world data

被引:0
作者
Joelle Constantin
Petar Atanasov
Daniel Wirth
Andras Borsi
机构
[1] Amaris,
[2] Janssen-Cilag GmbH,undefined
[3] Janssen EMEA,undefined
来源
BMC Gastroenterology | / 19卷
关键词
Inflammatory bowel disease; Ulcerative colitis; Indirect costs; Productivity loss; Financial burden; Real world evidence; Systematic literature review;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 48 条
  • [1] Michael MD(2014)Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics Eur J Health Econ 15 121-128
  • [2] Avitan AK(2016)The impact of inflammatory bowel disease on work productivity: comparison of a real-world sample of patients with Crohn’s disease and ulcerative colitis Value Health 19 A511-523
  • [3] Schwartz D(2010)Ulcerative colitis practice guidelines in adults: American college of gastroenterology, practice parameters committee Am J Gastroenterol 105 501-1725
  • [4] Greenberg D(2011)Medical progress in ulcerative colitis—review article N Engl J Med 365 1713-707
  • [5] Friger M(2010)How do patients with inflammatory bowel disease want their biological therapy administered? BMC Gastroenterol 10 1-1078
  • [6] Vardy H(2010)Systematic review: the costs of ulcerative colitis in Western countries Aliment Pharmacol Ther 31 693-12
  • [7] Sarid O(2015)Systematic review: the financial burden of surgical complications in patients with ulcerative colitis Aliment Pharmacol Ther 41 1066-1535
  • [8] Slonim-Nevo V(2007)Real-life data: a growing need ISPOR Connections 13 8-303
  • [9] Odes S(2016)Indirect costs of inflammatory bowel diseases: Crohn’s disease and ulcerative colitis. A systematic review Arch Med Sci 12 295-19
  • [10] Kornbluth A(2007)Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004 Inflamm Bowel Dis 13 1529-456